These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 35997366)

  • 1. Costs of Tuberculosis at 3 Treatment Centers, Canada, 2010-2016.
    Campbell JR; Nsengiyumva P; Chiang LY; Jamieson F; Khadawardi H; Mah HK; Oxlade O; Rasberry H; Rea E; Romanowski K; Sabur NF; Sander B; Uppal A; Johnston JC; Schwartzman K; Brode SK
    Emerg Infect Dis; 2022 Sep; 28(9):1814-1823. PubMed ID: 35997366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multidrug resistant tuberculosis in Ethiopian settings and its association with previous history of anti-tuberculosis treatment: a systematic review and meta-analysis.
    Eshetie S; Gizachew M; Dagnew M; Kumera G; Woldie H; Ambaw F; Tessema B; Moges F
    BMC Infect Dis; 2017 Mar; 17(1):219. PubMed ID: 28320336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence, treatment, and outcomes of isoniazid mono-resistant Mycobacterium tuberculosis infections in Alberta, Canada from 2007-2017.
    Edwards BD; Edwards J; Cooper R; Kunimoto D; Somayaji R; Fisher D
    PLoS One; 2020; 15(3):e0229691. PubMed ID: 32155169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of alcohol drinking and tobacco smoking on the drug-resistance of newly diagnosed tuberculosis: a retrospective cohort study in Shandong, China, during 2004-2020.
    Song WM; Li SJ; Liu JY; Fu Q; Xu TT; Tao NN; Zhang QY; Liu SQ; An QQ; Zhu XH; Liu Y; Yu CB; Li YF; Dong J; Li HC
    BMJ Open; 2022 Jul; 12(7):e059149. PubMed ID: 35902191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and factors associated with multidrug-resistant tuberculosis in South India.
    Shivekar SS; Kaliaperumal V; Brammacharry U; Sakkaravarthy A; Raj CKV; Alagappan C; Muthaiah M
    Sci Rep; 2020 Oct; 10(1):17552. PubMed ID: 33067551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Editorial: Updates from the World Health Organization (WHO) on Global Treatment Recommendations for Drug-Susceptible and Multidrug-Resistant Tuberculosis.
    Parums DV
    Med Sci Monit; 2021 Aug; 27():e934292. PubMed ID: 34366429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isoniazid mono-resistant tuberculosis: Time to take it seriously.
    Garg K; Saini V; Dhillon R; Agarwal P
    Indian J Tuberc; 2019 Apr; 66(2):247-252. PubMed ID: 31151492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evolving rifampicin and isoniazid mono-resistance in a high multidrug-resistant and extensively drug-resistant tuberculosis region: a retrospective data analysis.
    Mvelase NR; Balakrishna Y; Lutchminarain K; Mlisana K
    BMJ Open; 2019 Nov; 9(11):e031663. PubMed ID: 31699736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimating tuberculosis drug resistance amplification rates in high-burden settings.
    Karmakar M; Ragonnet R; Ascher DB; Trauer JM; Denholm JT
    BMC Infect Dis; 2022 Jan; 22(1):82. PubMed ID: 35073862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug-resistance patterns of Mycobacterium tuberculosis strains and associated risk factors among multi drug-resistant tuberculosis suspected patients from Ethiopia.
    Mesfin EA; Beyene D; Tesfaye A; Admasu A; Addise D; Amare M; Dagne B; Yaregal Z; Tesfaye E; Tessema B
    PLoS One; 2018; 13(6):e0197737. PubMed ID: 29864118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High Prevalence of inhA Promoter Mutations among Patients with Drug-Resistant Tuberculosis in KwaZulu-Natal, South Africa.
    Niehaus AJ; Mlisana K; Gandhi NR; Mathema B; Brust JC
    PLoS One; 2015; 10(9):e0135003. PubMed ID: 26332235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multidrug-resistant tuberculosis in Imo State, Southeast, Nigeria.
    E Ahiarakwem II; Ekejindu IM; Akujobi CN; Aghanya IN
    Niger J Clin Pract; 2020 Aug; 23(8):1172-1177. PubMed ID: 32788498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isoniazid-resistant tuberculosis: a cause for concern?
    Stagg HR; Lipman MC; McHugh TD; Jenkins HE
    Int J Tuberc Lung Dis; 2017 Feb; 21(2):129-139. PubMed ID: 28234075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Global isoniazid resistance patterns in rifampin-resistant and rifampin-susceptible tuberculosis.
    Smith SE; Kurbatova EV; Cavanaugh JS; Cegielski JP
    Int J Tuberc Lung Dis; 2012 Feb; 16(2):203-5. PubMed ID: 22136739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Costs to Health Services and the Patient of Treating Tuberculosis: A Systematic Literature Review.
    Laurence YV; Griffiths UK; Vassall A
    Pharmacoeconomics; 2015 Sep; 33(9):939-55. PubMed ID: 25939501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology of drug-resistant tuberculosis in New Jersey from 1991 to 1995.
    Liu Z; Shilkret KL; Finelli L
    Int J Epidemiol; 1998 Feb; 27(1):121-6. PubMed ID: 9563705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multidrug- and isoniazid-resistant tuberculosis in three high HIV burden African regions.
    Sanchez-Padilla E; Ardizzoni E; Sauvageot D; Ahoua L; Martin A; Varaine F; Adatu-Engwau F; Akeche G; Salaniponi F; Bonnet M
    Int J Tuberc Lung Dis; 2013 Aug; 17(8):1036-42. PubMed ID: 23827027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of isoniazid resistance-conferring mutations associated with multidrug-resistant tuberculosis in Free State Province, South Africa.
    Pitso L; Potgieter S; Van der Spoel van Dijk A
    S Afr Med J; 2019 Aug; 109(9):659-664. PubMed ID: 31635590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surveillance of drug resistance tuberculosis based on reference laboratory data in Ethiopia.
    Diriba G; Kebede A; Tola HH; Alemu A; Tadesse M; Tesfaye E; Mehamed Z; Meaza A; Yenew B; Molalign H; Dagne B; Sinshaw W; Amare M; Moga S; Abebaw Y; Sied G
    Infect Dis Poverty; 2019 Jun; 8(1):54. PubMed ID: 31200748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for multidrug-resistant tuberculosis in northwest Ethiopia: A case-control study.
    Alene KA; Viney K; McBryde ES; Gray DJ; Melku M; Clements ACA
    Transbound Emerg Dis; 2019 Jul; 66(4):1611-1618. PubMed ID: 30924283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.